Abstract
Homeopathic drug provings (HDPs) are a clinical research tool unique to homeopathy. They are used to gather qualitative information on the use of homeopathic medication in healthy subjects. This in turn guides prescribing with patients. HDPs offer a scientific method for new drug discovery, form part of the evidence base for homeopathy, and are sometimes compared with Phase I trials in conventional medicine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hahnemann S. Organon of Medicine: The First Integral English Translation of the Definitive Sixth Edition of the Original Work on Homoeopathic Medicine: A New Translation. Künzli J, Naudé A, Pendleton P, trans. London, UK: Victor Gollancz; 1983.
Higgins JPT, Savović J, Page MJ, Stern JAC, eds.; RoB2 Development Group. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). Published 22 August 2019. Accessed February 09, 2022. https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2.
Homoeopathic Pharmacopoeia Convention of the United States (HPCUS). HPCUS Proving Guidelines: Rev.2. April 11, 2015. Accessed February 09, 2022. http://www.hpus.com/HPCUS-Proving-Guidelines-2015.pdf.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2): Current Step 4 version dated 9 November 2016. Accessed February 09, 2022. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). About ICH: Mission. Accessed February 09, 2022. https://www.ich.org/page/mission.
Mathie RT, Hacke D, Clausen J, Nicolai T, Riley DS, Fisher P. Randomised controlled trials of homeopathy in humans: characterising the research journal literature for systematic review. Homeopathy. 2013;102:3–24. https://doi.org/10.1016/j.homp.2012.10.002.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.
Teut M, Hirschberg U, Luedtke R, et al. Protocol for a phase 1 homeopathic drug proving trial. Trials. 2010;11:80. https://doi.org/10.1186/1745-6215-11-80.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Riley, D.S. (2022). Homeopathic Drug Provings. In: Riley, D.S. (eds) Materia Medica of New and Old Homeopathic Medicines. Springer, Cham. https://doi.org/10.1007/978-3-030-65920-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-65920-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65919-6
Online ISBN: 978-3-030-65920-2
eBook Packages: MedicineMedicine (R0)